Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as epirubicin, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving
epirubicin before surgery may make the tumor smaller and reduce the amount of normal tissue
that needs to be removed.
PURPOSE: This phase II trial is studying how well epirubicin works in treating women who are
undergoing surgery for stage I, stage II, or stage III breast cancer.